Clinical Trial

Evaluation of Cochlear Implantation in Unilateral or Asymmetric Hearing Loss in Children.

Study acronym: AsymIC-Ped
Recruiting
View on ClinicalTrials.gov →
Summary
Today, unilateral hearing loss must be assessed and managed just as bilateral hearing loss is. It is recommended to consider the auditory difficulties caused by the loss of stereophonic hearing and to offer auditory rehabilitation as early as possible. Studies show that hearing devices can be effective in certain cases and for specific auditory modalities. The prognostic factors for successful hearing aid adaptation are linked to early intervention and the presence of residual hearing (using a BiCROS system). However, the cochlear implant remains the only device capable of potentially restoring contralateral auditory function in cases of single-sided deafness (SSD) and severe to profound unilateral hearing loss with asymmetrical deafness
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-15; most recent amendment 2026-03-24.
Status change: Not Yet Recruiting → Recruiting 2026-03-24
Trial Details
NCT Number NCT06930170
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Collaborators: URC-CIC Paris Descartes Necker Cochin
Conditions Unilateral Hearing Loss, Asymmetric Hearing Loss
Enrollment 36 participants
Start Date 2026-03-09
Primary Completion 2029-01 (estimated)
Study Completion 2029-04 (estimated)
Updated on ClinicalTrials.gov 2026-03-27